Related Experiment Video
Updated: Feb 28, 2026
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
6.4K
Sinonasal teratocarcinosarcoma: a case report.
Yi Chao Foong1,2, Vince Murdolo3, Nusa Naiman4
1Department of Radiation Oncology, Royal Hobart Hospital, 17 Liverpool St, Hobart, Tasmania, 7000, Australia. yi.foong@dhhs.tas.gov.au.
Journal of Medical Case Reports
|June 23, 2017
Summary
Radiotherapy alone can effectively treat residual sinonasal teratocarcinosarcoma after surgery. This approach offers a viable option for managing this rare and aggressive cancer, showing no recurrence in a 2-year follow-up.
Area of Science:
- Oncology
- Head and Neck Surgery
- Radiation Oncology
Background:
- Sinonasal teratocarcinosarcoma is a rare, aggressive malignancy.
- Histological features include carcinosarcoma and teratoma components.
- Optimal management remains unclear, often involving surgery and radiotherapy.
Observation:
- An 83-year-old woman presented with sinonasal teratocarcinosarcoma.
- Initial treatment involved surgical debulking.
- Radiological evidence of residual disease was noted post-surgery.
Findings:
- The patient received radiotherapy (60 Gy in 30 fractions) for residual disease.
- Follow-up at 2 years showed no evidence of recurrence.
- Radiotherapy alone demonstrated efficacy in this case.
Implications:
- Radiotherapy may be an effective standalone treatment for residual sinonasal teratocarcinosarcoma post-surgery.
- This finding could influence future treatment strategies for this rare cancer.
- Highlights the potential of radiotherapy in managing aggressive sinonasal malignancies.
